Skip to content

Cencora, Inc.

COR · XNYS

CIK 1140859fmd_18Y14P9WG059CFMBDNBX7X96W9Wholesale Trade · Wholesale-Drugs, Proprietaries & Druggists' SundriesTemplate: Standard

Coverage: Oct 01, 2006 to Jun 30, 2026, 74 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues146,850153,144167,940179,589189,894213,989238,587262,173293,959321,333
Cost of revenue142,577148,598163,327174,451184,702207,046230,291253,214284,049309,854
Net interest income––––––––––
Gross profit4,2734,5464,6125,1385,1926,9438,2968,9599,91011,479
Selling, general and administrative2,0912,1292,4602,6642,7673,5944,8495,3105,6616,494
Total operating expenses–––––––5,7236,0936,992
Operating income1,5261,0601,4441,112(5,135)2,3542,3662,3412,1752,629
Other non-operating income (expense)53(25)132422749(14)(79)
Income before taxes1,3919181,177967(5,294)2,2222,1832,1612,0042,258
Income tax expense(37)553(438)113(1,894)677517428485691
Net income from continuing operations1,4283641,616854(3,400)1,5451,6671,7331,5191,568
Net income1,4283641,658855(3,409)1,5401,6991,7451,5091,554